Ron Winslow April 17, 2016 F. Stephen Hodi (Dana-Farber) led a study finding that more than one-third of advanced melanoma patients treated with Opdivo, a caner immunotherapy agent, have survived at least five years. Read the full article
CTE Is Caused by More Than Head Trauma, New Study Suggests October 30, 2025 Research reveals Alzheimer’s disease-like DNA damage, hints at immune involvement
How Much Are Concierge Medicine and Direct Primary Care Growing? December 18, 2025 Study quantifies surge transforming U.S. health care
Harvard Medical School’s Top Science News of 2025 December 18, 2025 10 biomedical discoveries that expand knowledge, may improve health
